日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced Shock

MPS-Authors
/persons/resource/persons77998

Geiger,  Tamar
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

Shir, A., Klein, S., Sagiv-Barfi, I., Geiger, T., Zigler, M., Langut, Y., Edinger, N., & Levitzki, A. (2018). S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced Shock. Journal of Infectious Diseases, 217(2), 288-297. doi:10.1093/infdis/jix576.


引用: https://hdl.handle.net/21.11116/0000-0003-121E-8
要旨
Superantigens (SAgs) are extremely potent bacterial toxins, which evoke a virulent immune response, inducing nonspecific T-cell proliferation, rapid cytokine release, and lethal toxic shock, for which there is no effective treatment. We previously developed a small molecule, S101, which potently inhibits proliferating T cells. In a severe mouse model of toxic shock, a single injection of S101 given together with superantigen challenge rescued 100% of the mice. Even when given 2 hours after challenge, S101 rescued 40% of the mice. S101 targets the T-cell receptor, inflammatory response, and actin cytoskeleton pathways. S101 inhibits the aryl hydrocarbon receptor, a ligand-activated transcription factor that is involved in the differentiation of T-helper cells, especially Th17, and regulatory T cells. Our results provide the rationale for developing S101 to treat superantigen-induced toxic shock and other pathologies characterized by T-cell activation and proliferation.